Pharmaceutical translation: why accuracy matters
Translation in the pharmaceutical industry is far more than a purely linguistic task: it plays a critical role in ensuring patient safety, regulatory compliance and the commercial success of products in international markets. Translating patient information leaflets, labels, promotional materials and technical documentation requires a thorough understanding of medical terminology, country-specific regulations and a high level of linguistic precision.
According to Grand View Research, the global life sciences translation services market was valued at USD 1.7 billion in 2025 and is projected to reach USD 3.3 billion by 2033, growing at a compound annual growth rate of 8.5% between 2026 and 2033. This growth is driven by the expansion of international clinical trials, increasing demand for regulatory compliance and the continued globalisation of the pharmaceutical and biotechnology industries.
The importance of accurate translation is also reflected in patient safety. Medication errors can occur at different stages of treatment, and unclear instructions, confusing labelling or poorly presented information can increase the risk of misunderstandings. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) provides guidance on the labelling and packaging of medicines, emphasising the importance of clear information to support safe medicine selection and use and help reduce medication errors.
Against this background, regulatory authorities such as the European Medicines Agency (EMA), the Spanish Agency for Medicines and Medical Devices (AEMPS) and the US Food and Drug Administration (FDA) establish requirements for the clarity, accuracy and consistency of pharmaceutical information. These requirements vary depending on the market, the type of document and the applicable regulatory framework.
Why accurate translation matters
Patient safety is closely linked to translation quality. A poorly translated patient information leaflet can lead to dosing errors, misunderstandings about possible adverse reactions or confusion about how a medicine should be administered.
For this reason, translating pharmaceutical materials requires not only an excellent command of the relevant languages but also specialist knowledge of medical terminology, pharmacokinetics and pharmacovigilance. Technical expertise is essential when interpreting abbreviations, international nomenclature, acronyms and units of measurement, which may vary between countries and healthcare systems.
High-quality translation also has a direct impact on a pharmaceutical brand’s reputation and the trust it inspires. Poorly adapted technical language or linguistic errors in promotional materials can create a negative impression of a product before it even reaches the patient.
Pharmaceutical companies operating internationally increasingly recognise the importance of localising their content. This not only helps them meet regulatory requirements but also strengthens their competitiveness in multilingual markets.
Promotional materials, including brochures, presentations for healthcare professionals, social media content and websites, therefore require careful adaptation that combines terminological accuracy, cultural sensitivity and commercial relevance.
Real challenges in pharmaceutical translation
Translating for the pharmaceutical industry involves a range of linguistic, technical and legal challenges. A good command of the language alone is not enough.
Translators must work with highly specialised terminology that often varies between countries and even between different medical disciplines. The same term may have different meanings in oncology, cardiology or neurology, making context and terminological precision essential to avoiding misunderstandings that could have clinical consequences.
Pharmaceutical documents are also subject to strict and evolving regulations. Each country or region has its own requirements governing how information about medicines must be written, presented and structured. Meeting these requirements involves more than producing an accurate translation: the text must also be adapted to the appropriate format, terminology and regulatory conventions.
In this sense, pharmaceutical translation becomes a process of technical localisation that demands exceptional attention to detail.
Confidentiality is another significant challenge. Documents requiring translation often contain highly sensitive information, from clinical trial data and safety reports to commercial launch strategies. Translators may be required to sign non-disclosure agreements (NDAs) and work within secure environments that protect the confidentiality and integrity of the information.
On top of these challenges comes the pressure of tight deadlines. In an industry where time to market can have major financial implications, translations must be delivered efficiently without compromising accuracy.
This is why many pharmaceutical companies work with teams of specialist translators who use translation memories, terminology databases, glossaries and computer-assisted translation (CAT) tools to maintain consistency, improve efficiency and support quality control.
What Do You Need Translated?
Planning a pharmaceutical translation project? Answer three quick questions and prepare a personalised enquiry for ALOS.
What types of documents are translated in the pharmaceutical sector?
The range of documents requiring translation in the pharmaceutical industry is extensive, covering information intended for patients, healthcare professionals and regulatory authorities.
One of the most familiar examples is the patient information leaflet (PIL), also known as the package leaflet. This contains essential information about a medicine, including dosage, indications, contraindications, possible side effects and warnings. The information must be clear, accessible and appropriately adapted to the language and regulatory requirements of the market in which the medicine is sold.
Another important document is the summary of product characteristics (SmPC), which provides more detailed technical information for healthcare professionals. These documents require precise, specialised language, as they include pharmacodynamic information, interactions with other medicines and important clinical data.
In the European Union, the European Medicines Agency provides Quality Review of Documents (QRD) templates to support the consistent presentation of product information, including SmPCs, labelling and package leaflets. These templates are an important reference for translators working with pharmaceutical documentation intended for the European market.
In marketing, pharmaceutical companies need to translate promotional materials such as brochures, product presentations, websites, social media content and sales materials for their commercial teams.
Although these documents may be less technical than patient information leaflets, they are subject to strict rules governing the claims that can be made about medicines. Their translation therefore requires the same level of care and attention as clinical documentation.
Other important materials include labels and packaging, which must contain accurate information about composition, expiry dates, batch numbers, instructions for use and relevant warnings. Even minor wording differences can cause misunderstandings or result in regulatory non-compliance.
Finally, there are pharmacovigilance reports, informed consent forms and clinical trial protocols. Accurate translation of these documents is essential for supporting regulatory processes and enabling participation in international clinical studies.
Common abbreviations every pharmaceutical translator should know
When translating pharmaceutical documents, professionals frequently encounter abbreviations that are essential to understanding the terminology and regulatory context.
- EMA: European Medicines Agency.
- AEMPS: Spanish Agency for Medicines and Medical Devices.
- FDA: US Food and Drug Administration.
- SmPC: Summary of Product Characteristics.
- PIL: Patient Information Leaflet.
- QRD: Quality Review of Documents.
- NDA: Non-Disclosure Agreement.
- ICH: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
- GMP: Good Manufacturing Practice.
- CTD: Common Technical Document.
Understanding these abbreviations is essential for maintaining terminological consistency and ensuring that translated documents meet the relevant technical and regulatory requirements.
As this article has shown, accurate translation of patient information leaflets, technical documentation and promotional materials plays a crucial role in protecting patient safety and meeting regulatory requirements in the pharmaceutical industry.
Working with specialist language professionals helps ensure clear, reliable communication across international markets, protecting both patients and pharmaceutical companies.
Why choose ALOS Soluciones Lingüísticas?
At ALOS Soluciones Lingüísticas, we understand that accurate translation is essential in highly regulated sectors such as pharmaceuticals, where every term matters and even a small error can have serious consequences.
We offer comprehensive language solutions designed to support accurate and effective communication:
- Professional translation services: specialist translations adapted to the demanding requirements of the pharmaceutical sector, with a focus on terminological accuracy, consistency and regulatory requirements.
- Tailored language courses: specialist language training for professionals who need to use technical terminology confidently and improve international communication within the pharmaceutical industry.
With our experience in specialised translation and professional language training, we help companies communicate effectively in a highly competitive and regulated global market.
Contact ALOS Soluciones Lingüísticas to find out how we can support your pharmaceutical translation needs.
PHARMACEUTICAL TRANSLATION WHERE EVERY WORD MATTERS
From patient information leaflets to technical and regulatory documentation, ALOS helps pharmaceutical companies communicate clearly and accurately across international markets.
Frequently Asked Questions (FAQs)
Because even a small translation error can lead to misunderstandings about dosage, possible side effects or instructions for use, potentially putting patient safety at risk. Clear and accurate information helps patients use medicines safely.
Requirements vary by country and document type. In the European Union, pharmaceutical product information must comply with applicable EU legislation and relevant regulatory guidance, including the EMA’s Quality Review of Documents (QRD) templates where applicable.
Pharmaceutical translators need excellent linguistic skills, specialist knowledge of medical and pharmaceutical terminology, an understanding of regulatory requirements and the ability to work accurately with complex technical documentation.
Working with specialist translators or language service providers familiar with pharmaceutical regulations is an important step. Appropriate terminology management, expert review and quality-control procedures also help reduce errors and support regulatory compliance.
ALOS provides specialised translation services for pharmaceutical documentation, including patient information leaflets, technical documents, promotional materials and regulatory content. We also offer revision and localisation services to help companies communicate clearly across international markets.
Our approach focuses on specialist linguistic expertise, consistent terminology and appropriate review and quality-control processes, adapted to the requirements of each project.
Yes. In addition to specialised translation, ALOS provides tailored language training for professionals working in the pharmaceutical and healthcare sectors, helping them communicate more confidently and effectively in international environments.
